Información:
Error:
ID
13068
Descripción
SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00487448
Link
https://clinicaltrials.gov/show/NCT00487448
Palabras clave
Versiones (1)
- 14/1/16 14/1/16 -
Titular de derechos de autor
CC BY-NC 3.0
Subido en
14 de enero de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Myelodysplastic Syndrome NCT00487448
Eligibility Myelodysplastic Syndrome NCT00487448
- StudyEvent: Eligibility
Similar models
Eligibility Myelodysplastic Syndrome NCT00487448
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
age
Item
age < 75 years
boolean
C0001779 (UMLS CUI [1])
myelodysplastic syndrome
Item
diagnosis of myelodysplastic syndrome in order to fab criteria, excluding patients with chronic myeloid leukemia.
boolean
C3463824 (UMLS CUI [1])
IPI
Item
ipi > 1 (high risk or intermedia risk-2) and/or ipe equal or > 3 (high risk o intermedia risk) or secondary acute myeloid leukemia.
boolean
C1512894 (UMLS CUI [1])
toxicity
Item
resolved toxicity for previous treatments received to myelodysplastic syndrome .
boolean
C0600688 (UMLS CUI [1])
myelodysplastic syndrome de novo.
Item
myelodysplastic syndrome de novo.
boolean
C3463824 (UMLS CUI [1])
neoplasia
Item
associated neoplasia.
boolean
C1882062 (UMLS CUI [1])
chronic disease that can limit the patient follow up protocol
Item
chronic disease that can limit the patient follow up protocol (cardiovascular disease, active infection uncontrolled, etc.).
boolean
C2348563 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
age < 55 years with related donor hla compatible
Item
age < 55 years with related donor hla compatible.
boolean
C0001779 (UMLS CUI [1])
C0019721 (UMLS CUI [2])
C0019721 (UMLS CUI [2])
investigational drug
Item
use an investigational drug in the 30 previous days.
boolean
C0013230 (UMLS CUI [1])
chemotherapy
Item
previous treatment with chemotherapy agents.
boolean
C0392920 (UMLS CUI [1])
simultaneous treatment
Item
simultaneous treatment during the study with other drugs not allowed in the protocol.
boolean
C0087111 (UMLS CUI [1])
bilirubin and gpt
Item
bilirubin > 2 mg/dl and gpt >2 times the normal value.
boolean
C1278039 (UMLS CUI [1])
C1557189 (UMLS CUI [2])
C1557189 (UMLS CUI [2])
creatinine
Item
creatinine > 2 mg/dl.
boolean
C0201976 (UMLS CUI [1])
hypersensibility
Item
hypersensibility to agents used in the protocol.
boolean
C0020517 (UMLS CUI [1])
secondary mds to chemo-radiotherapy .
Item
secondary mds to chemo-radiotherapy .
boolean
C3463824 (UMLS CUI [1])
hiv
Item
hiv positive.
boolean
C0019682 (UMLS CUI [1])
CML
Item
chronic myeloblastic leukemia
boolean
C0023474 (UMLS CUI [1])